Stocktoria
Vivani Medical, Inc. VANI
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2014-12-05
Vivani Medical, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — |
| Gross profit | — | — | — | — | $130,000 |
| R&D expense | $18.1M | $15.7M | $17.0M | $14.2M | $11.0M |
| Operating income | -$27.6M | -$24.7M | -$27.0M | -$21.2M | -$13.3M |
| Income tax | — | $2,000 | — | — | — |
| Net income | -$26.6M | -$23.5M | -$25.7M | -$13.9M | -$12.8M |
| EPS (diluted) | $-0.43 | $-0.43 | $-0.50 | — | — |
| Operating cash flow | -$24.3M | -$20.8M | -$23.7M | -$18.8M | -$11.0M |
| Free cash flow | -$25.5M | -$21.3M | -$24.6M | -$19.1M | -$11.5M |
| Cash & equivalents | $16.2M | $18.4M | $20.7M | $45.1M | $2.2M |
| Total assets | $39.4M | $41.6M | $45.8M | $51.1M | $5.5M |
| Total liabilities | $23.7M | $24.0M | $25.0M | $6.8M | $3.0M |
| Shareholders' equity | $15.7M | $17.6M | $20.8M | $44.3M | $2.5M |
Source: SEC EDGAR filings · CIK 0001266806 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.